A Simplified, Fully Defined Differentiation Scheme for Producing Blood-Brain Barrier Endothelial Cells from Human iPSCs
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Human induced pluripotent stem cell (iPSC)-derived developmental lineages are key tools for in vitro mechanistic interrogations, drug discovery, and disease modeling. iPSCs have previously been differentiated to endothelial cells with blood-brain barrier (BBB) properties, as defined by high transendothelial electrical resistance (TEER), low passive permeability, and active transporter functions. Typical protocols use undefined components, which impart unacceptable variability on the differentiation process. We demonstrate that replacement of serum with fully defined components, from common medium supplements to a simple mixture of insulin, transferrin, and selenium, yields BBB endothelium with TEER in the range of 2,000–8,000 Ω × cm 2 across multiple iPSC lines, with appropriate marker expression and active transporters. The use of a fully defined medium vastly improves the consistency of differentiation, and co-culture of BBB endothelium with iPSC-derived astrocytes produces a robust in vitro neurovascular model. This defined differentiation scheme should broadly enable the use of human BBB endothelium for diverse applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280 · cited 3×
“Disruption of the BBB is strongly implicated in many neurodegenerative diseases (Zlokovic, 2008), and its functions are also influenced by peripheral conditions that can reduce its fidelity and result in CNS damage (Huber et al.”
BackgroundDevelopment, maintenance and disruption of the blood-brain barrier
Obermeier, B., Daneman, R., & Ransohoff, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3407 · Cited by 2,452 · cited 1×
“The blood-brain barrier (BBB) is composed of brain microvascular endothelial cells (BMECs), which strictlymaintain CNS homeostasis by regulatingmaterial exchange between the bloodstream and parenchyma (Obermeier et al., 2013).”
BackgroundHelms, H. C., Abbott, N. J., Burek, M., Cecchelli, R., Couraud, P.-O., Deli, M. A., Förster, C., Galla, H. J., Romero, I. A., Shusta, E. V., et al. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16630991 · Cited by 843
Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells
Lippmann, E. S., Azarin, S. M., Kay, J. E., Nessler, R. A., Wilson, H. K., Al-Ahmad, A., Palecek, S. P., & Shusta, E. V. (2012) · Nature Biotechnology · doi:10.1038/nbt.2247 · Cited by 800 · cited 1×
“In 2012, human pluripotent stem cells (hPSCs) were successfully differentiated to BMECs, as determined by increased transendothelial electrical resistance (TEER) ( 850 U 3 cm(2)), representative permeability to a cohort of small molecules, and active efflux transporter function (Lippmann et al., 2012).”
BackgroundSelf-citationLippmann, E. S., Al-Ahmad, A., Azarin, S. M., Palecek, S. P., & Shusta, E. V. (2014) · Scientific Reports · doi:10.1038/srep04160 · Cited by 508
Self-citationAppelt-Menzel, A., Cubukova, A., Günther, K., Edenhofer, F., Piontek, J., Krause, G., Stüber, T., Walles, H., Neuhaus, W., & Metzger, M. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.02.021 · Cited by 274
Directed differentiation of human pluripotent stem cells to blood-brain barrier endothelial cells
Qian, T., Maguire, S. E., Canfield, S. G., Bao, X., Olson, W. R., Shusta, E. V., & Palecek, S. P. (2017) · Science Advances · doi:10.1126/sciadv.1701679 · Cited by 254
Canfield, S. G., Stebbins, M. J., Morales, B. S., Asai, S. W., Vatine, G. D., Svendsen, C. N., Palecek, S. P., & Shusta, E. V. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13923 · Cited by 250
Vatine, G. D., Al-Ahmad, A., Barriga, B. K., Svendsen, S., Salim, A., Garcia, L., Garcia, V. J., Ho, R., Yucer, N., Qian, T., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.04.002 · Cited by 233
Cerebrovascular Permeability Coefficients to Sodium, Potassium, and Chloride
Smith, Q. R., & Rapoport, S. I. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb08491.x · Cited by 196
Hollmann, E. K., Bailey, A. K., Potharazu, A. V., Neely, M. D., Bowman, A. B., & Lippmann, E. S. (2017) · Fluids and Barriers of the CNS · doi:10.1186/s12987-017-0059-0 · Cited by 189
Self-citationWilson, H. K., Canfield, S. G., Hjortness, M. K., Palecek, S. P., & Shusta, E. V. (2015) · Fluids and Barriers of the CNS · doi:10.1186/s12987-015-0007-9 · Cited by 130 · cited 3×
“advancements in standardization of the differentiation process (Hollmann et al., 2017; Wilson et al., 2015), more work is needed to achieve optimum results.”
BackgroundResult
Research works printed but not linked: 14
- Banks, 2016, From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery, Nat. Rev. Drug Discov., 15, 275, 10.1038/nrd.2015.21 · DOI · Paper page
- Bernas, 2010, Establishment of primary cultures of human brain microvascular endothelial cells to provide an in vitro cellular model of the blood-brain barrier, Nat. Protoc., 5, 1265, 10.1038/nprot.2010.76 · DOI · Paper page
- Brewer, 1993, Optimized survival of hippocampal neurons in B27-supplemented neurobasal™, a new serum-free medium combination, J. Neurosci. Res., 35, 567, 10.1002/jnr.490350513 · DOI · Paper page
- Huber, 2001, Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression, Am. J. Physiol. Heart Circ. Physiol., 280, H1241, 10.1152/ajpheart.2001.280.3.H1241 · DOI · Paper page
- Kumar, 2014, Cellular manganese content is developmentally regulated in human dopaminergic neurons, Sci. Rep., 4, 6801, 10.1038/srep06801 · DOI · Paper page
- Lim, 2017, Huntington’s disease iPSC-derived brain microvascular endothelial cells reveal WNT-mediated angiogenic and blood-brain barrier deficits, Cell Rep., 19, 1365, 10.1016/j.celrep.2017.04.021 · DOI · Paper page
- Lippmann, 2014, Defined human pluripotent stem cell culture enables highly efficient neuroepithelium derivation without small molecule inhibitors, Stem Cells, 32, 1032, 10.1002/stem.1622 · DOI · Paper page
- Mannello, 2007, Stem Cells, 25, 1603, 10.1634/stemcells.2007-0127 · DOI · Paper page
- Mantle, 2016, Minimum transendothelial electrical resistance thresholds for the study of small and large molecule drug transport in a human in vitro blood-brain barrier model, Mol. Pharm., 13, 4191, 10.1021/acs.molpharmaceut.6b00818 · DOI · Paper page
- Salvador, 2014, Glucocorticoids and endothelial cell barrier function, Cell Tissue Res., 355, 597, 10.1007/s00441-013-1762-z · DOI
- Stebbins, 2017, Activation of RARα, RARγ, or RXRα increases barrier tightness in human induced pluripotent stem cell-derived brain endothelial cells, Biotechnol. J., 13, 1700093, 10.1002/biot.201700093 · DOI · Paper page
- Syvänen, 2009, Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport, Drug Metab. Dispos., 37, 635, 10.1124/dmd.108.024745 · DOI · Paper page
- Tidball, 2016, Genomic instability associated with p53 knockdown in the generation of Huntington’s disease human induced pluripotent stem cells, PLoS One, 11, e0150372, 10.1371/journal.pone.0150372 · DOI
- Weksler, 2005, Blood-brain barrier-specific properties of a human adult brain endothelial cell line, FASEB J., 19, 1872, 10.1096/fj.04-3458fje · DOI · Paper page
Cited by
Neuronal regulation of the blood–brain barrier and neurovascular coupling
Kaplan, L., Chow, B. W., & Gu, C. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0322-2 · Cited by 430
The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice
Rhea, E. M., Logsdon, A. F., Hansen, K. M., Williams, L. M., Reed, M. J., Baumann, K. K., Holden, S. J., Raber, J., Banks, W. A., & Erickson, M. A. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00771-8 · Cited by 419
Kim, H., Leng, K., Park, J., Sorets, A. G., Kim, S., Shostak, A., Embalabala, R. J., Mlouk, K., Katdare, K. A., Rose, I. V. L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34412-4 · Cited by 201
Self-citationSun, J., Ou, W., Han, D., Paganini-Hill, A., Fisher, M. J., & Sumbria, R. K. (2022) · PLOS ONE · doi:10.1371/journal.pone.0268860 · Cited by 47
“However, consistent with previous work, we found a distinct junctional rather than the cytoplasmic location of claudin-5 in the ihBMECs [14, 20], whereas both junctional and cytoplasmic claudin-5 expression was observed in the bEnd.”
BackgroundResultGupta, R., Chauhan, A., Kaur, T., Kuanr, B. K., & Sharma, D. (2022) · Nanoscale · doi:10.1039/d2nr02210a · Cited by 35
Metadata
- Authors
- Neal, E. H., Marinelli, N. A., Shi, Y., McClatchey, P. M., Balotin, K. M., Gullett, D. R., Hagerla, K. A., Bowman, A. B., Ess, K. C., Wikswo, J. P., & Lippmann, E. S.
- Venue
- Stem Cell Reports
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 12
- Issue
- 6
- Pages
- 1380-1388
- ISSN
- 2213-6711 (ISSN-L)
- OpenAlex
- W2949682332
- Cited by
- 208
- References
- 12
- FWCI
- 8.88
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- Brain and Behavior Research Foundation
- BrightFocus Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.